Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Valuation

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

PAO-06-022--NI-12June 24, 2022

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-02June 24, 2022

Investment Recovery for Pharma Equipment – Part 2

Investment Recovery for Pharma Equipment – Part 2

Matt Hicks

Federal Equipment Company

PAP-Q03-16-CL-010August 01, 2016

Investment Recovery for Pharma Equipment – Part 1

Investment Recovery for Pharma Equipment – Part 1

Matt Hicks

Federal Equipment Company

PAP-Q02-16-CL-006April 01, 2016

1 / 1